M

Middle East Pharmaceutical Industries Company SJSC
SAU:4016

Watchlist Manager
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Watchlist
Price: 121.2 SAR 1.68% Market Closed
Market Cap: 2.4B SAR
Have any thoughts about
Middle East Pharmaceutical Industries Company SJSC?
Write Note

Middle East Pharmaceutical Industries Company SJSC
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Middle East Pharmaceutical Industries Company SJSC
Accrued Liabilities Peer Comparison

Comparables:
2070
J
4015

Competitive Accrued Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
M
Middle East Pharmaceutical Industries Company SJSC
SAU:4016
Accrued Liabilities
ď·Ľ17m
CAGR 3-Years
19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
SAU:2070
Accrued Liabilities
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
J
Jamjoom Pharmaceuticals Factory Company SJSC
SAU:4015
Accrued Liabilities
ď·Ľ86.1m
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Middle East Pharmaceutical Industries Company SJSC's Accrued Liabilities?
Accrued Liabilities
17m SAR

Based on the financial report for Dec 31, 2023, Middle East Pharmaceutical Industries Company SJSC's Accrued Liabilities amounts to 17m SAR.

What is Middle East Pharmaceutical Industries Company SJSC's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 3Y
19%

Over the last year, the Accrued Liabilities growth was 75%. The average annual Accrued Liabilities growth rates for Middle East Pharmaceutical Industries Company SJSC have been 19% over the past three years .

Back to Top